세계 신경 서방형 치료제 시장

Using formulation technologies designed to modulate the effect of therapeutic substances, drug developers are creating formulations that exhibit extended release profiles. These chemistries include polymers such as polyethylene glycol-complexed (PEGylated), which are used to product encapsulated and coated versions of new APIs. The goal is to address the requirement for patient-dependent, and therefore compliance-sensitive, drug treatment protocols such as multiple dosing through controlled release formulations that provide the desired therapeutic effect with dosing of once-a-day or less.

The report provides developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, opportunities for injection devices that are designed for patient self-administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

Features:

• Numerous graphs, charts, tables and visualizations complement the analysis

• Forecasts, projections of future market activity are derived using standard modeling and statistical techniques.

What You Will Learn:

• Analyzes and evaluates modified release neurology therapeutics products and assesses the market potential for existing and probable future products

• Analyzes product strategies, technologies and market development issues

• Provides detailed analysis of neurology market segments, market demographics, and therapeutic strategies

• Profiles market sector companies, their product development activities, business strategies, and corporate alliances and affiliations

• Evaluates the impact of economic, technology, and regulatory factors on neurology drug markets

Table of Contents

Executive Summary

The Market Opportunity

• Executive Summary
• The Neurological Drug Market Dynamics
• The Trend Toward Self-Administration
• Route of Administration
• Innovation in Drug Formulation
• Neurological Drugs and As-supplied Packaging
• Human Engineering/Ergonomics
• Delivering Neurological Drugs via Injection
• Primary Packaging
• Innovation in Injectable Device Designs
• Drug Delivery Device Selection Issues
• Therapeutic Demand Drivers
• Key Market Factors
• MR Neurological Product Analysis
• Proprietary Formulation Technology
• ChroniJect (Oakwood Laboratories/PharmaSophia)
• CriticalMix (Critical Pharmaceuticals)
• Depofoam (Pacira)
• FluidCrystal (Camarus)
• LinkeRx (Alkermes)
• Medisorb (Alkermes)
• Medusa (Recipharm/Avadel)
• Nanocrystals (Alkermes)
• Optisomes (Talon/Spectrum)
• PolyActive (Octoplus)
• Q-Sphera (Midatech Pharma)
• SABER/SAIB (DURECT)
• SynBiosys (Innocore)
• TransCon (Ascendis)
• Physical Process Control Methods
• Supercritical Fluid
• SCF for Nanoparticle Formulations
• Formulplex (Supercritical Solutions)
• Ferro
• SCF extraction of emulsions (SFEE)
• Stability
• Administration Factors
• Therapeutic Market Sectors
• Schizophrenia
• Bipolar Disorder
• Market Sector Analysis and Forecasts
• Key Market Factors
• Economic Factors
• Technology Factors
• Regulatory Factors
• Risk Factors
• Forecasts and Market Data
• Company Profiles